3k3a-Apc Restores Oligodendrocyte Pools In Models Of White Matter Stroke Via Par1 Signaling.
Stroke(2021)
摘要
A recombinant variant of activated protein C, 3K3A-APC, was recently tested in a successful phase II clinical trial for ischemic stroke (RHAPSODY), which demonstrated that the treatment may reduce ...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要